Technologies

at the heart of every formulation

For over 20 years, Bioformula has been developing proprietary technologies that set a higher standard, thanks to the purity of the raw materials, the rigor of the production process, and the stability of the formulation over time.

Pharmaceutical-grade hyaluronic acid fiber
High-molecular-weight polynucleotides
Isoosmolar formulation at physiological pH
Low BDDE residue

Pharmaceutical-grade hyaluronic acid fiber

Premium Technology – Bioformula Products

Most biorevitalizing products on the market use hyaluronic acid powder. Bioformula has chosen a pharmaceutical-grade fiber raw material that, unlike common powder, preserves the structural integrity of the polymer throughout the entire production process.

The result is a high-molecular-weight hyaluronic acid that:

  • guarantees unprecedented hygroscopic capacity
  • offers prolonged resistance to enzymatic degradation
  • ensures a minimal inflammatory profile and total biocompatibility
  • reducing the post-treatment tissue reaction

High-molecular-weight polynucleotides—derived from Alaskan salmon

Exclusive Technology – Plenhyage XL Line

The quality of polynucleotides depends on their source. Ours are derived from wild Alaskan salmon, caught in pristine waters and naturally free of hormones, antibiotics, and pollutants from aquaculture—the global gold standard for biological integrity.

The raw material is extracted from salmon gonads certified by the FDA for food use; it is a byproduct of the MSC (Marine Stewardship Council)-certified supply chain and is subject to a comprehensive traceability system.

At the dermal level, high-molecular-weight polynucleotides act as a biomimetic scaffold:

1
Biological priming and structural support
2
Tissue stress resolution and resilience
3
Deep hydration and hydro-homeostasis
4
Holistic vitality and brightness

Clinical data show a 115% improvement in hydration levels and a 38% improvement in skin elasticity at 20 weeks, with 63% of patients classified as “very much improved” on the GAIS scale and no treatment-related adverse events.

Isoosmolar formulation at physiological pH

Process Technology — Plenhyage XL Line

Plenhyage XL is designed based on parameters that most products on the market do not simultaneously guarantee. An excellent active ingredient is not enough if the formulation that delivers it does not respect the physiology of the tissues.

For this reason, the solution is calibrated to closely match the natural osmolality of human tissues — the further a formulation deviates from this, the greater the risk of cellular irritation and a burning sensation during injection. The pH is carefully controlled to remain within the optimal physiological range, as values outside this range directly activate pain receptors in the tissues. The chosen carrier is neutral saline, free of unnecessary excipients: maximum concentration of the active ingredient, uniform diffusion, and maintained isotonicity. The result is a more tolerable injection experience — for both the patient and the healthcare professional.

Isoosmolality

The solution is formulated to closely match the natural osmolality of human tissues. The further a formulation deviates from physiological values, the greater the risk of irritation and a burning sensation during injection.

physiological pH

A pH level outside the target range activates pain receptors in the tissues. Our formulation is carefully controlled to remain within the optimal range.

Essential Composition

carrier in neutral saline solution, with no unnecessary excipients. The result is maximum concentration of the active ingredient, uniform distribution in the tissues, and a more tolerable injection experience—for both the patient and the healthcare professional.

Low BDDE residue

Process Standards — Evanthia Line

BDDE is the standard cross-linker used in the cross-linking of hyaluronic acid, and its residual concentration in the finished product is a key safety parameter.

Evanthia fillers are manufactured in accordance with the most stringent European requirements for Class III Medical Devices (CE 0373). For this reason, BDDE residue is monitored, controlled, and certified for every single batch through an integrated quality system.

Thanks to Bioformula’s vertically integrated production model, control of this parameter is guaranteed at every stage of the process, ensuring high standards of repeatability, traceability, and compliance in every production cycle.

The result is a cross-linked filler with high-performance volumizing and contouring capabilities, capable of combining clinical efficacy with a safety profile that meets regulatory standards and patient expectations.

Quality Control System – Production Standards

Bioformula Infrastructure

All of Bioformula’s technologies are brought together in an in-house production facility spanning over 40,000 m², one of the most advanced in the world in the field of medical devices for aesthetic medicine.

Each batch is subject to monitoring and full traceability systems prior to release.

Our certifications:

“We don’t want to stop time, but to put it at the service of beauty”